Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 359

Similar articles for PubMed (Select 19530027)

1.

Clozapine use in treatment-resistant agitation in the setting of dementia.

Bastiampillai T, Dhillon R, French TH.

Aust N Z J Psychiatry. 2009 Jul;43(7):689-90. doi: 10.1080/00048670902970924. No abstract available.

PMID:
19530027
2.

Clozapine for treatment-resistant agitation in dementia.

Lee HB, Hanner JA, Yokley JL, Appleby B, Hurowitz L, Lyketsos CG.

J Geriatr Psychiatry Neurol. 2007 Sep;20(3):178-82.

PMID:
17712102
3.

Clozapine for the treatment of agitated-depressed patients with cognitive impairment: a report of three cases.

Nacasch N, Dolberg OT, Hirschmann S, Dannon P, Grunhaus LJ.

Clin Neuropharmacol. 1998 Mar-Apr;21(2):132-4.

PMID:
9579302
4.

Treatment strategies for agitation and psychosis in dementia.

Tariot PN.

J Clin Psychiatry. 1996;57 Suppl 14:21-9. Review.

PMID:
9024333
5.

The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances.

Kunik ME, Puryear L, Orengo CA, Molinari V, Workman RH Jr.

Int J Geriatr Psychiatry. 1998 Jan;13(1):29-34.

PMID:
9489578
6.

Pharmacologic approach to management of agitation associated with dementia.

Kunik ME, Yudofsky SC, Silver JM, Hales RE.

J Clin Psychiatry. 1994 Feb;55 Suppl:13-7. Review.

PMID:
7915710
7.

Chronic restlessness with antipsychotics.

Bratti IM, Kane JM, Marder SR.

Am J Psychiatry. 2007 Nov;164(11):1648-54. Review. No abstract available.

PMID:
17974927
8.

[State of agitation. Diagnostic guidance and procedures in emergencies along with drug dosage recommendations].

Haffen E, Sechter D.

Rev Prat. 1998 May 15;48(10):1123-7. Review. French. No abstract available.

PMID:
9781159
9.

Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.

Mintzer JE, Brawman-Mintzer O.

J Clin Psychiatry. 1996;57 Suppl 7:55-63; discussion 73-5. Review.

PMID:
8690698
10.

[Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].

Kudo T.

Seishin Shinkeigaku Zasshi. 2007;109(7):657-63. Review. Japanese. No abstract available.

PMID:
17969953
11.

[Treatment of agitation in dementia patients].

González Salvador MT, Arango López C, Lyketsos CG.

Med Clin (Barc). 1999 Nov 6;113(15):592-7. Review. Spanish. No abstract available.

PMID:
10605687
12.

Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs.

Caspi A, Reichenberg A, Weiser M, Rabinowitz J, Shmushkevich M, Lubin G, Nahon D, Vishne T, Davidson M.

Schizophr Res. 2007 Aug;94(1-3):45-9. Epub 2007 Jun 4.

PMID:
17544633
13.

Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder.

Lambert M, Huber CG, Naber D, Schacht A, Wagner TT, Hundemer HP, Karow A, Schimmelmann BG.

Pharmacopsychiatry. 2008 Sep;41(5):182-9. doi: 10.1055/s-2008-1077050. Epub 2008 Sep 1.

PMID:
18763220
14.

Sedation in acute and chronic agitation.

Levy RH.

Pharmacotherapy. 1996 Nov-Dec;16(6 Pt 2):152S-159S; discussion 166S-168S. Review.

PMID:
8947999
15.

High-dose olanzapine for treatment-resistant schizophrenia.

Roth BL.

J Clin Psychiatry. 2008 Feb;69(2):176-7. No abstract available.

PMID:
18363451
16.

Cognitive dysfunction in schizophrenia.

Lublin H.

Acta Psychiatr Scand Suppl. 2001;(408):5-9. No abstract available.

PMID:
11730073
17.

Severe withdrawal akathisia following neuroleptic discontinuation successfully controlled by clozapine.

Poyurovsky M, Hermesh H, Weizman A.

Int Clin Psychopharmacol. 1996 Dec;11(4):283-6.

PMID:
9031996
18.

Are high initial doses of olanzapine required to reduce agitation associated with schizophrenia?

Townsend MH, Baier MB.

J Clin Psychopharmacol. 2004 Feb;24(1):95-7. No abstract available.

PMID:
14709956
19.

Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.

Zaraa AS.

Geriatrics. 2003 Oct;58(10):48-50, 52-3. Review. No abstract available.

PMID:
14569642
20.

Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case report.

Mobascher J, Zielasek J, Schuier FJ, Mobascher A, Grohmann R, Agelink MW, Cordes J.

Pharmacopsychiatry. 2005 Nov;38(6):329-30.

PMID:
16342008
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk